Alright, let’s geek out hard on the gepants

Alright, let’s geek out hard on the gepants—these small-molecule CGRP receptor antagonists that finally ditched the hepatotoxicity baggage of the first-gen olcegepant/telcagepant era. We’re talking high-affinity, canonical CGRP receptor blockade (not AMY1...